VIRGAN

This brand name is authorized in France, Hong Kong SAR China, Poland, Romania, Singapore, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug VIRGAN contains one active pharmaceutical ingredient (API):

1	Ganciclovir UNII P9G3CKZ4P5 - GANCICLOVIR
	Ganciclovir, 9-(1,3-dihydroxy-2-propoxymethyl)guanine or DHPG, is a broadspectrum virustatic agent which inhibits the replication of viruses, including viruses of the herpes group, both in vivo and in vitro: herpes simplex types 1 and 2 (HSV), cytomegalovirus (CMV), Epstein-Barr virus (EBV), herpes zoster (HZV).
	Read more about Ganciclovir

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
VIRGAN Eye gel	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01AD09	Ganciclovir	S Sensory organs → S01 Ophthalmologicals → S01A Antiinfectives → S01AD Antivirals
Discover more medicines within S01AD09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
ES	Centro de información online de medicamentos de la AEMPS	67075
FR	Base de données publique des médicaments	62985373
GB	Medicines & Healthcare Products Regulatory Agency	369081, 374092, 381755, 39766
HK	Department of Health Drug Office	61397
PL	Rejestru Produktów Leczniczych	100145296, 100425995, 100429390, 100450710
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W43702001
SG	Health Sciences Authority	11778P
TN	Direction de la Pharmacie et du Médicament	8443031
TR	İlaç ve Tıbbi Cihaz Kurumu	8680177220092